Andrew Berens
Stock Analyst at Leerink Partners
(4.83)
# 402
Out of 4,371 analysts
538
Total ratings
46.9%
Success rate
22.5%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $28.68 | +49.93% | 2 | May 15, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $10 → $55 | $22.15 | +148.31% | 26 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 → $33 | $19.68 | +67.68% | 14 | May 15, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $46 → $51 | $22.31 | +128.60% | 2 | May 15, 2026 | |
| AURA Aura Biosciences | Maintained: Buy | $22 → $17 | $6.80 | +150.00% | 27 | May 12, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 → $11 | $2.13 | +416.43% | 26 | Apr 27, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $23 | $11.00 | +109.09% | 1 | Mar 20, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $41 | $8.23 | +398.18% | 3 | Mar 6, 2026 | |
| RLMD Relmada Therapeutics | Initiated Coverage: Buy | $8 | $6.31 | +26.78% | 1 | Jan 23, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | $34 → $40 | $28.79 | +38.94% | 51 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $40 | $25.10 | +59.36% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $97 | $92.47 | +4.90% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $149 | $94.02 | +58.48% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $32.79 | +52.49% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.48 | +234.82% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $48 | $52.49 | -8.55% | 12 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $29.22 | +12.94% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.43 | - | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $4.30 | +667.44% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $14.54 | -17.47% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.47 | +104.08% | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $279.93 | +23.25% | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $7.74 | +16.28% | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.87 | +29.20% | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $9.21 | +95.44% | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $103 | $101.24 | +1.74% | 61 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $133.06 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $57.07 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 → $25 | $4.17 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $17.36 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.60 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $7.01 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $87.61 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $8.80 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.6974 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9703 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $43.53 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $129.18 | n/a | 3 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.79 | n/a | 2 | Dec 1, 2014 |
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $28.68
Upside: +49.93%
Tango Therapeutics
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $22.15
Upside: +148.31%
Immunome
May 15, 2026
Maintained: Buy
Price Target: $40 → $33
Current: $19.68
Upside: +67.68%
Damora Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $46 → $51
Current: $22.31
Upside: +128.60%
Aura Biosciences
May 12, 2026
Maintained: Buy
Price Target: $22 → $17
Current: $6.80
Upside: +150.00%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $7 → $11
Current: $2.13
Upside: +416.43%
Adlai Nortye
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $11.00
Upside: +109.09%
BridgeBio Oncology Therapeutics
Mar 6, 2026
Reiterated: Buy
Price Target: $41
Current: $8.23
Upside: +398.18%
Relmada Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $6.31
Upside: +26.78%
Agios Pharmaceuticals
Dec 25, 2025
Maintained: Buy
Price Target: $34 → $40
Current: $28.79
Upside: +38.94%
Nov 19, 2025
Maintained: Buy
Price Target: $24 → $40
Current: $25.10
Upside: +59.36%
Nov 17, 2025
Maintained: Buy
Price Target: $70 → $97
Current: $92.47
Upside: +4.90%
Nov 17, 2025
Maintained: Buy
Price Target: $140 → $149
Current: $94.02
Upside: +58.48%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $32.79
Upside: +52.49%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $4.48
Upside: +234.82%
Oct 21, 2025
Upgraded: Buy
Price Target: $38 → $48
Current: $52.49
Upside: -8.55%
Oct 21, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $29.22
Upside: +12.94%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $14.43
Upside: -
Aug 13, 2025
Maintained: Buy
Price Target: $33
Current: $4.30
Upside: +667.44%
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $14.54
Upside: -17.47%
Aug 11, 2025
Maintained: Hold
Price Target: $3
Current: $1.47
Upside: +104.08%
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $279.93
Upside: +23.25%
Aug 7, 2025
Maintained: Hold
Price Target: $9
Current: $7.74
Upside: +16.28%
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $3.87
Upside: +29.20%
Aug 5, 2025
Maintained: Buy
Price Target: $18.00
Current: $9.21
Upside: +95.44%
Jul 30, 2025
Maintained: Buy
Price Target: $96 → $103
Current: $101.24
Upside: +1.74%
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $133.06
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: n/a
Current: $57.07
Upside: n/a
Feb 7, 2023
Maintained: Buy
Price Target: $67 → $25
Current: $4.17
Upside: n/a
Feb 7, 2023
Maintained: Hold
Price Target: $20 → $15
Current: $17.36
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: n/a
Current: $11.60
Upside: n/a
May 7, 2021
Maintained: Hold
Price Target: $10
Current: $7.01
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Maintained: Hold
Price Target: $23
Current: $87.61
Upside: n/a
Jul 14, 2017
Maintained: Hold
Price Target: $16 → $8
Current: $8.80
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $0.6974
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.9703
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $43.53
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $129.18
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $11.79
Upside: n/a